THE RELATION OF ATHEROGENIC OXIDATIVE-ANTIOXIDANT SHIFTS IN LOW DENSITY LIPOPROTEIDES WITH ADVERSE LONG-TERM PROGNOSIS IN MALES

Aim. To study the baseline parameters of potentially atherogenic oxidativeantioxidant changes of low-density lipoproteides (LDL) with adverse 7-year longterm outcomes.Material and methods. In male population (n=1024, aged 47-73 year-old) by biochemistry we assessed the values of baseline and catalyz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rossiĭskiĭ kardiologicheskiĭ zhurnal 2016 (12), p.45-48
Hauptverfasser: Ragino, Yu. I., Voevoda, M. I., Malyutina, S. K., Gafarov, V. V., Shishkin, S. V., Bogatyrev, S. N., Scherbakova, L. V., Polonskaya, Ya. V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim. To study the baseline parameters of potentially atherogenic oxidativeantioxidant changes of low-density lipoproteides (LDL) with adverse 7-year longterm outcomes.Material and methods. In male population (n=1024, aged 47-73 year-old) by biochemistry we assessed the values of baseline and catalyzation stimulated oxidation of peroxidated lipids products (LOP) in LDL, concentration of antioxidants in LDL (alpha-tocopherol, beta-carotene, retinol, xantines), concentration of antibodies to oxidized LDL (oxLDL). Then, during 7 years with the use of Registers we assessed endpoints: myocardial infarction, stroke, total and cardiovascular mortality.Results. The significant associations revealed, of the baseline LDL products content (p=0,019, Hazard Ratio, HR=1,39) and resistance of LDL to oxidation at early stage (p=0,048, HR=1,18) with the stroke cases. Also, the significant relations found of beta-carotene in LDL (p=0,034, HR=0,98) and antibodies concentration against oxLDL (p=0,041, HR=0,99) with cardiovascular mortality cases in 7 year follow-up.Conclusion. The data represents significant pathogenetic role of atherogenic oxidation-antioxidant changes of LDL in development of cardiovascular diseases and complications.
ISSN:1560-4071
2618-7620
DOI:10.15829/1560-4071-2016-12-45-48